Patents by Inventor Suchitra Sumitran Holgersson

Suchitra Sumitran Holgersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOENGINEERED ALLOGENEIC VALVE
    Publication number: 20200383785
    Abstract: The present disclosure relates to methods for recellularization of valves in valve-bearing veins. This method is useful for producing an allogeneic venous valve, wherein a donor valve-bearing vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic valves produced by the methods disclosed herein are advantageous for implantation, transplantation, or grafting into patients with vascular diseases.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 10, 2020
    Applicant: VeriGraft AB
    Inventors: Suchitra SUMITRAN-HOLGERSSON, Antonio Rosales, Jonny Hisdal
  • BIOENGINEERED ALLOGENEIC BLOOD VESSEL
    Publication number: 20200147272
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: May 14, 2020
    Applicant: VeriGraft AB
    Inventors: Suchitra SUMITRAN-HOLGERSSON, Michael OLAUSSON
  • Bioengineered allogeneic blood vessel
    Patent number: 10517996
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 31, 2019
    Assignee: Verigraft AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • COMPOSITIONS AND METHODS FOR HEALING WOUNDS
    Publication number: 20180303970
    Abstract: The present disclosure relates to a composition of an engineered biomaterial including extracellular matrix components of a mammalian tissue and a polymer; method of wound healing; and methods delivering therapeutic agents, growth factors, or hydration for wound healing to a subject in need thereof.
    Type: Application
    Filed: October 28, 2016
    Publication date: October 25, 2018
    Inventor: Suchitra Sumitran-Holgersson
  • BIOENGINEERED ALLOGENEIC BLOOD VESSEL
    Publication number: 20180055973
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: April 7, 2017
    Publication date: March 1, 2018
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Bioengineered allogeneic blood vessel
    Patent number: 9662421
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: May 30, 2017
    Assignee: NOV AHEP AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Bioengineered Allogeneic Valve
    Publication number: 20170071738
    Abstract: The present disclosure relates to methods for recellularization of valves in valve-bearing veins. This method is useful for producing an allogeneic venous valve, wherein a donor valve-bearing vein is decellularized and then recelluiarized using whole blood or bone marrow stem cells. The allogeneic valves produced by the methods disclosed herein are advantageous for implantation, transplantation, or grafting into patients with vascular diseases.
    Type: Application
    Filed: May 27, 2015
    Publication date: March 16, 2017
    Inventors: Suchitra Sumitran-Holgersson, Antonio Rosales, Jonny Hisdal
  • Bioengineered Allogeneic Blood Vessel
    Publication number: 20170049935
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: June 1, 2016
    Publication date: February 23, 2017
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Bioengineered allogeneic blood vessel
    Patent number: 9433706
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: September 6, 2016
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • BIOENGINEERED ALLOGENEIC BLOOD VESSEL
    Publication number: 20160045642
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: May 28, 2015
    Publication date: February 18, 2016
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Bioengineered allogeneic blood vessel
    Patent number: 9090879
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: July 28, 2015
    Assignee: NOVAHEP AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Bioengineered Allogeneic Blood Vessel
    Publication number: 20140377864
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: March 1, 2013
    Publication date: December 25, 2014
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Methods of donor specific crossmatching
    Patent number: 8173372
    Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating Tie-2+ and CD34? precursor endothelial cells for use in donor-specific crossmatching.
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: May 8, 2012
    Assignee: AbSorber AB
    Inventor: Suchitra Sumitran-Holgersson
  • Methods of donor specific crossmatching
    Patent number: 8034635
    Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies and methods for donor-specific crossmatching.
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: October 11, 2011
    Assignee: AbSorber AB
    Inventor: Suchitra Sumitran Holgersson
  • ENDOTHELIAL PROGENITOR CELLS AND METHODS OF USE THEREOF
    Publication number: 20090148423
    Abstract: Endothelial progenitor cells immunoreactive for VEGFR-2 or Tie-2, and CD45 are provided. Optionally the cell is immunoreactive with CD14. The cells are capable of differentiating in vivo into an endothelial cell or a smooth muscle cells. The cultures integrate well after transplantation into adult vasculature.
    Type: Application
    Filed: December 8, 2008
    Publication date: June 11, 2009
    Inventor: Suchitra Sumitran-Holgersson
  • METHODS OF DONOR SPECIFIC CROSSMATCHING
    Publication number: 20090142780
    Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies and methods for donor-specific crossmatching.
    Type: Application
    Filed: December 2, 2008
    Publication date: June 4, 2009
    Inventor: Suchitra Sumitran Holgersson
  • Methods of donor specific crossmatching
    Publication number: 20050244404
    Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies for donor-specific crossmatching.
    Type: Application
    Filed: May 16, 2005
    Publication date: November 3, 2005
    Inventors: Suchitra Sumitran-Holgersson, Per Grufman
  • Endothelial progenitor cells and methods of use thereof
    Publication number: 20050201990
    Abstract: Endothelial progenitor cells immunoreactive for VEGFR-2 or Tie-2, and CD45 are provided. Optionally the cell is immunoreactive with CD14. The cells are capable of differentiating in vivo into an endothelial cell or a smooth muscle cells. The cultures integrate well after transplantation into adult vasculature.
    Type: Application
    Filed: March 9, 2005
    Publication date: September 15, 2005
    Inventor: Suchitra Sumitran-Holgersson
  • Methods of donor specific crossmatching
    Publication number: 20030228638
    Abstract: The detection of endothelial cell antibodies has been proven clinically important for successful organ transplantation. Disclosed are methods of isolating endothelial cell antibodies for donor-specific crossmatching.
    Type: Application
    Filed: May 16, 2003
    Publication date: December 11, 2003
    Inventor: Suchitra Sumitran-Holgersson